 | Pieris Pharmaceuticals, Inc. | |||
| NCM : PIRS || Location: United States | ||||
$11.6-0.33 (-2.77%) |
0.03 M | 11.38 - 11.74 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.000 M |
| March 28, 2024 | 0.134 M |
| March 15, 2024 | 0.042 M |
| Feb. 29, 2024 | 0.071 M |
| Feb. 15, 2024 | 0.066 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.11 | 0.04 | 135.65% |
| 06/30/2023 | -0.16 | 0.05 | 130.64% |
| 03/31/2023 | -0.14 | -0.18 | -26.05% |
| 12/31/2022 | -0.23 | -0.11 | 53.11% |
| 09/30/2022 | -0.16 | -0.13 | 18.80% |
PIRS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 1.237M | Shares Float | 0.765M |
| Short Float | 0.000M | Market Cap | 14.35M |
| Institution ownership | 39.50% | Insider ownership | 7.435% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -21.60 | Forward EPS | -0.20 |